AUTLAutolus Therapeutics plcvs its industry peers
A metric-by-metric comparison of Autolus Therapeutics plc against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUTL본 종목 | $506M#3 | — | 6.8x#2 | 6.7x#3 | 644.9%#1 | -30.3%#5 | -358.9%#4 | -384.2%#2 | — | — | 44.5%#3 | — |
| AGTX | — | — | — | — | -100.0%#5 | 14.4%#4 | — | — | — | — | — | — |
| ALVOW | $100M#5 | — | — | 0.2x#1 | 19.7%#4 | 112.0%#2 | 13.3%#3 | — | — | — | -70.9%#5 | — |
| APGE | $10.2B#2 | — | — | — | — | -40.5%#6 | — | — | — | — | 254.5%#1 | — |
| APTN | — | — | — | — | — | -65.5%#7 | — | — | — | — | — | — |
| ARGX | $60.6B#1 | — | — | 1705.6x#4 | 254.4%#2 | 55.1%#3 | 2965.7%#1 | — | — | — | 30.5%#4 | — |
| CGEN | $228M#4 | 6.4x#1 | 2.2x#1 | 3.1x#2 | 161.1%#3 | 348.4%#1 | 43.1%#2 | 34.4%#1 | — | — | 75.6%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice